J&J in Talks to Sell DePuy Synthes to Apollo for $20 Billion

J&J in talks to sell DePuy Synthes to Apollo for $20 billion

Apollo is in discussions to acquire DePuy Synthes, which generated $9.3 billion in sales last year and could also be spun off as a public company

Apollo rumoured to be eyeing $20bn takeover of J&J’s orthopaedics business

Alternative asset management company Apollo Global Management is reportedly in talks to acquire Johnson & Johnson's (J&J) orthopaedics unit through a multi-billion-dollar deal. According to Bloomberg, which first shared this development, Apollo and J&J are currently in non-binding talks that could…

Apollo Global Is in Talks for Johnson & Johnson’s DePuy Synthes Orthopedics Unit Near $20 Billion:

HedgeCo.Net — Apollo Global Management is in talks to acquire Johnson & Johnson’s DePuy Synthes orthopedics unit at a valuation close to $20 billion, according to people familiar with the matter cited by Bloomberg on September 11 and independently carried by Reuters and The Wall Street Journal. Coverage framed the discussions as live but unfinished: an agreement could come within weeks, or talks could end without a deal, another bidder could eme…

Apollo in talks to acquire J&J’s DePuy Synthes for around $20bn

TOP STORY: Apollo Global Management is in discussions to acquire Johnson & Johnson’s DePuy Synthes orthopaedics business in a deal that could value the unit at close to $20bn, according to a report by Bloomberg citing unnamed people familiar with the matter.